The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

This lengthy study with the drug Mounjaro seems to point to even better success than they’d hoped. Eli Lilly, the mind behind ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

Teva Pharmaceutical Industries will pay $450 to settle the Department of Justice's investigation into allegations of price fixing and misuse of funds for kickbacks. Other pharmaceutical news reports ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S.

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

A voguish — and often daunting — problem can plague people who have experienced recent and relatively rapid weight loss.